NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Cross Above l Day Moving Average of $0.00

Posted by on Jul 23rd, 2022

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Become Rating) passed above its fifty day moving boilerplate during trading on Friday . The stock has a fifty day moving average of $0.00 and traded equally high every bit $0.27. NovaBay Pharmaceuticals shares last traded at $0.24, with a volume of 266,594 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Ascendiant Upper-case letter Markets reduced their price objective on shares of NovaBay Pharmaceuticals from $4.25 to $four.00 in a research note on Friday, May 20th.

NovaBay Pharmaceuticals Price Performance

The stock has a market cap of $12.63 million, a cost-to-earnings ratio of -1.41 and a beta of 3.47.

Institutional Trading of NovaBay Pharmaceuticals

A hedge fund recently raised its stake in NovaBay Pharmaceuticals stock. Virtu Fiscal LLC increased its holdings in shares of NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Go Rating) by 260.4% during the 1st quarter, according to its most contempo filing with the Securities and Exchange Commission (SEC). The institutional investor owned 163,451 shares of the biopharmaceutical company's stock after purchasing an additional 118,099 shares during the catamenia. Virtu Fiscal LLC owned approximately 0.31% of NovaBay Pharmaceuticals worth $48,000 at the terminate of the most contempo quarter. ii.64% of the stock is currently owned by institutional investors.

NovaBay Pharmaceuticals Company Profile

(Go Rating)

NovaBay Pharmaceuticals, Inc, a pharmaceutical company, develops and sells eyecare and skincare products in the United states and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and droppings from skin effectually the eye, such as the eyelid; and wound intendance products under the NeutroPhase and PhaseOne brands.

Featured Articles

  • Get a free re-create of the StockNews.com research report on NovaBay Pharmaceuticals (NBY)
  • Three Watchlist Stocks to Capitalize on Sector Rotation
  • MarketBeat: Calendar week in Review 7/18 – 7/22
  • Falling Copper Prices Counterbalance On Freeport McMoran'southward Earnings, But Long Term Fundamentals Intact
  • Verizon Shares Driblet On Earnings Miss, Lower Guidance
  • Snap Stock Falters Every bit Growth Slows To Tape Low

Want More than Great Investing Ideas?

  • Bear Market Game Plan!
  • The 10 Best Stocks to Own in 2022
  • seven Stocks to Purchase and Concur Forever
  • 3 Stocks to DOUBLE This Year

Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your electronic mail address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily electronic mail newsletter.

You might be interested in: